Literature DB >> 32583223

Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection.

Toshimichi Onuma1, Tetsuji Kurokawa2, Akiko Shinagawa2, Yoko Chino2, Yoshio Yoshida2.   

Abstract

BACKGROUND: To adopt HPV self-sampling in Japan, we assessed the concordance between self- and physician-collected human papillomavirus (HPV) samples from Japanese patients and examined the performance of HPV self-sampling for cervical intraepithelial neoplasia grade 2 or worse (CIN2+).
METHODS: Patients who had previously tested negative for intraepithelial lesions or malignancy/HPV-positive, and patients with atypical squamous cells of undetermined significance or worse (ASCUS+) cytology were eligible for this cross-sectional study. Participants performed HPV self-sampling using an Evalyn brush, which was submitted at the Fukui Prefectural Health Care Association. The Evalyn brush heads were stored in ThinPrep vials. The physician, however, performed HPV and cell sampling using an endocervical brush and immediately stored the brush heads in ThinPrep vials. All participants underwent colposcopy and biopsy. Histopathological diagnoses were made by pathologists at Fukui University Hospital. HPV infection was confirmed using a PCR-based Cobas 4800 HPV DNA test. Cytological analysis was performed at Fukui Prefectural Health Care Association.
RESULTS: HPV-positive rates for physician-collected samples and self-collected samples were 51 and 50%, respectively. The perfect match rate of HPV type between the groups was 88% (κ = 0.76). HPV16/18 showed higher agreement rates than other HPVs (99%, kappa 0.96 and 89% kappa 0.77, respectively). Both groups showed 100% sensitivity to CIN2+, but specificity was 57.0 and 58.1%, respectively.
CONCLUSION: For HPV typing, a good concordance rate was seen between self- and physician-collected samples. Self-sampling showed high sensitivity for CIN2+. Self-sampling using the Evalyn brush and Cobas 4800 may be feasible for screening Japanese individuals.

Entities:  

Keywords:  Brush; Cervical cancer; HPV self-sampling; PCR-based HPV test; Screening

Year:  2020        PMID: 32583223     DOI: 10.1007/s10147-020-01727-5

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  6 in total

1.  Utility of Scoring System for Screening and Early Warning of Cervical Cancer Based on Big Data Analysis.

Authors:  Dan Hou; Binjie Yang; Yangdan Li; Ming Sun
Journal:  Front Public Health       Date:  2022-06-20

2.  High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.

Authors:  Teboho Amelia Tiiti; Tebogo Loraine Mashishi; Varsetile Varster Nkwinika; Ina Benoy; Selokela Gloria Selabe; Johannes Bogers; Ramokone Lisbeth Lebelo
Journal:  Virol J       Date:  2021-09-23       Impact factor: 4.099

3.  Comparison of self-collected versus clinician collected cervicovaginal specimens for detection of high risk human papillomavirus among HIV infected women in Ethiopia.

Authors:  Agajie Likie Bogale; Tilahun Teklehaymanot; Jemal Haidar Ali; Getnet Mitike Kassie; Girmay Medhin; Ajanaw Yizengaw Baye; Amelework Yilma Shiferaw
Journal:  BMC Womens Health       Date:  2022-09-01       Impact factor: 2.742

4.  Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial.

Authors:  Misuzu Fujita; Kengo Nagashima; Minobu Shimazu; Misae Suzuki; Ichiro Tauchi; Miwa Sakuma; Setsuko Yamamoto; Hideki Hanaoka; Makio Shozu; Nobuhide Tsuruoka; Tokuzo Kasai; Akira Hata
Journal:  Sci Rep       Date:  2022-08-25       Impact factor: 4.996

5.  ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cells of undetermined significance: a diagnostic test.

Authors:  Ling Wang; Qingxia Song; Ying Liu; Qiang Ou
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

6.  Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.

Authors:  Misuzu Fujita; Minobu Shimazu; Kengo Nagashima; Misae Suzuki; Ichiro Tauchi; Miwa Sakuma; Setsuko Yamamoto; Makio Shozu; Hideki Hanaoka; Nobuhide Tsuruoka; Tokuzo Kasai; Akira Hata
Journal:  BMJ Open       Date:  2022-02-03       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.